Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Jan;73(1):262–266. doi: 10.1172/JCI111200

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

R M Evans, G C Doelle, J Lindner, V Bradley, D Rabin
PMCID: PMC425009  PMID: 6228566

Abstract

The effect of the luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6,Pro9-NEth]LHRH (LHRHA), on luteinizing hormone (LH) bioactivity was assessed with a rat interstitial cell assay in four men during a 14-d treatment period. Biologic/immunologic (B/I) ratios were unchanged initially with treatment but by day 12 had fallen to levels lower than basal values. Frequent sampling on day 12 revealed blunted gonadotropin responsiveness to LHRHA and absence of spontaneous LH pulsations. Despite continued administration of LHRHA, human chorionic gonadotropin administration resulted in elevated B/I ratios and testosterone levels. Further characterization of the serum immunoreactive LH by Sephadex chromatography revealed a later elution profile during treatment with LHRHA. Thus, LHRHA appears to act, in part, by modification of the bioactivity of LH in man.

Full text

PDF
262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beitins I. Z., Axelrod L., Ostrea T., Little R., Badger T. M. Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: characterization of the abnormal hormone. J Clin Endocrinol Metab. 1981 Jun;52(6):1143–1149. doi: 10.1210/jcem-52-6-1143. [DOI] [PubMed] [Google Scholar]
  2. Benveniste R., Frohman L. A., Rabinowitz D. Heterogeneity of purified human pituitary luteinizing hormone: effect on hormone measurement by radioimmunoassay. Endocrinology. 1975 Jul;97(1):20–29. doi: 10.1210/endo-97-1-20. [DOI] [PubMed] [Google Scholar]
  3. Chen H. C., Shimohigashi Y., Dufau M. L., Catt K. J. Characterization and biological properties of chemically deglycosylated human chorionic gonadotropin. Role of carbohydrate moieties in adenylate cyclase activation. J Biol Chem. 1982 Dec 10;257(23):14446–14452. [PubMed] [Google Scholar]
  4. Dufau M. L., Beitins I. Z., McArthur J. W., Catt K. J. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects. J Clin Endocrinol Metab. 1976 Sep;43(3):658–667. doi: 10.1210/jcem-43-3-658. [DOI] [PubMed] [Google Scholar]
  5. Dufau M. L., Catt K. J., Tsuruhara T. Retention of in vitro biological activities by desialylated human luteinizing hormone and chorionic gonadotropin. Biochem Biophys Res Commun. 1971 Sep;44(5):1022–1029. doi: 10.1016/s0006-291x(71)80188-2. [DOI] [PubMed] [Google Scholar]
  6. Dufau M. L., Mendelson C. R., Catt K. J. A highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin: testosterone production by dispersed Leydig cells. J Clin Endocrinol Metab. 1974 Sep;39(3):610–613. doi: 10.1210/jcem-39-3-610. [DOI] [PubMed] [Google Scholar]
  7. Dufau M. L., Pock R., Neubauer A., Catt K. J. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay. J Clin Endocrinol Metab. 1976 May;42(5):958–969. doi: 10.1210/jcem-42-5-958. [DOI] [PubMed] [Google Scholar]
  8. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lucky A. W., Rebar R. W., Rosenfield R. L., Roche-Bender N., Helke J. Reduction of the potency of luteinizing hormone by estrogen. N Engl J Med. 1979 May 3;300(18):1034–1036. doi: 10.1056/NEJM197905033001808. [DOI] [PubMed] [Google Scholar]
  10. Peckham W. D., Knobil E. The effects of ovariectomy, estrogen replacement, and neuraminidase treatment on the properties of the adenohypophysial glycoprotein hormones of the Rhesus monkey. Endocrinology. 1976 Apr;98(4):1054–1060. doi: 10.1210/endo-98-4-1054. [DOI] [PubMed] [Google Scholar]
  11. Peckham W. D., Yamaji T., Dierschke D. J., Knobil E. Gonadal function and the biological and physicochemical properties of follicle stimulating hormone. Endocrinology. 1973 Jun;92(6):1660–1666. doi: 10.1210/endo-92-6-1660. [DOI] [PubMed] [Google Scholar]
  12. Sawyer-Steffan J. E., Lasley B. L., Hoff J. D., Yen S. S. Comparison of in-vitro bioactivity and immunoreactivity of serum LH in normal cyclic and hypogonadal women treated with low doses of LH-RH. J Reprod Fertil. 1982 May;65(1):45–51. doi: 10.1530/jrf.0.0650045. [DOI] [PubMed] [Google Scholar]
  13. Strickland T. W., Puett D. Contribution of subunits to the function of luteinizing hormone/human chorionic gonadotropin recombinants. Endocrinology. 1981 Dec;109(6):1933–1942. doi: 10.1210/endo-109-6-1933. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES